By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Karolinska Development AB 

Fogdevreten 2, Solna

Stockholm    S-171 77  Sweden
Phone: 46-0-8-524-865-91 Fax: n/a



Company News
Karolinska Development AB Release: Company Portfolio Company Promimic AB Appoints Magnus Larsson As New CEO And Launches US Sales Operation 1/18/2017 12:47:33 PM
Karolinska Development AB Portfolio Company Dilafor Initiates Phase IIb Clinical Trial With Tafoxiparin In Women With Protracted Labor 1/4/2017 8:43:21 AM
Karolinska Development AB Company Modus To Present Poster At 58th American Society of Hematology Annual Meeting In San Diego 12/1/2016 9:06:54 AM
Karolinska Development AB: Interim Report For January-September 2016 11/23/2016 9:06:04 AM
Karolinska Development AB – Q3 2016 Interim Report - Invitation To Conference Call And Webcast 11/17/2016 11:11:27 AM
Karolinska Development AB Company Modus Therapeutics’ Ongoing Clinical Study With Sevuparin In Sickle Cell Disease Expands To Include Adolescent Patients 11/15/2016 9:58:10 AM
Karolinska Development AB Modus Therapeutics Granted U.S. Patents For Sickle Cell Disease Drug Candidate Sevuparin 11/7/2016 9:26:28 AM
Karolinska Development AB Umecrine Cognition Announces Positive Phase 1 Data With GR3027 In Hepatic Encephalopathy 11/3/2016 8:55:16 AM
Karolinska Development AB Company Dilaforette To Change Name To Modus Therapeutics And Announces Intention To Conduct An Initial Public Offering 10/20/2016 10:13:57 AM
Karolinska Development AB Portfolio Company Promimic AB And Danco Announce Completion Of U.S. Production Line For Hanano Surface Medical Implant Coating 10/19/2016 9:23:34 AM